Clinical Supply Intern jobs in United States
cer-icon
Apply on Employer Site
company-logo

AstraZeneca · 1 day ago

Clinical Supply Intern

AstraZeneca is looking for Sophomore and Junior students for a 10-week internship role at their Alexion: AstraZeneca Rare Disease site in Boston, MA. The role involves supporting clinical supply execution, process improvement, and leveraging data and AI for various projects.

BiopharmaBiotechnologyHealth CareMedicalPharmaceuticalPrecision Medicine
check
Comp. & Benefits
badNo H1Bnote

Responsibilities

Support forecasting, kit design, packaging/labeling, depot setup, inventory and temperature controls, and GxP documentation
Map workflows, analyze cycle times/errors, standardize templates/SOPs, and apply lean methods
Build dashboards and predictions from ERP/IRT data; pilot AI for demand sensing, anomaly detection, label checks, and shipment prioritization with quality oversight

Qualification

ExcelPowerBIProject managementPublic speakingPresentation designCollaboration

Required

Sophomore and Junior students majoring in Biological Sciences, Business Administration, or a related field
Candidates must have an expected graduation date after August 2026
Basic experience with Excel and PowerBI
Project management skills such as adaptability, time management, and process improvement
Enthusiasm for collaboration, cross-functional projects, public speaking, and presentation design
US Work Authorization is required at time of application
Ability to report onsite to the Seaport neighborhood in Boston, MA site 4-5 days per week

Benefits

Short-term incentive bonus opportunity
Equity-based long-term incentive program (salaried roles)
Retirement contribution (hourly roles)
Commission payment eligibility (sales roles)
Qualified retirement program [401(k) plan]
Paid vacation and holidays
Paid leaves
Health benefits including medical, prescription drug, dental, and vision coverage

Company

AstraZeneca

company-logo
AstraZeneca is a pharmaceutical company that discovers, develops, manufactures, and markets prescription medicines. It is a sub-organization of Investor.

Funding

Current Stage
Public Company
Total Funding
$5.26B
2024-07-30Post Ipo Debt· $1.51B
2023-02-28Post Ipo Debt· $2.25B
2023-02-24Post Ipo Debt· $1.5B

Leadership Team

leader-logo
Pascal Soriot
Executive Director and Chief Executive Officer
leader-logo
Aradhana Sarin
Group CFO and Executive Director
linkedin
Company data provided by crunchbase